Dhivy Coupons & Discount Card – Guaranteed Prices from $4.60

The following safety information highlights important risks and necessary precautions when using Sinemet (carbidopa/levodopa). Please read carefully and consult your healthcare provider with any questions or concerns.

• Sleepiness and Sudden Sleep Episodes: This medication may cause unexpected sleepiness or sudden sleep episodes. Avoid driving or engaging in activities that require full attention until you know how Sinemet affects you. This is particularly important if you have a history of drowsiness, sleep problems, or are taking other sedative medications. Inform your healthcare provider if you experience excessive daytime sleepiness or fall asleep during activities that require concentration.

• Risk of Neuroleptic Malignant Syndrome (NMS): Abruptly stopping or reducing the dose of Sinemet may lead to symptoms similar to NMS, a serious condition characterized by high fever, confusion, irregular pulse, sweating, muscle stiffness, and blood pressure changes. Do not discontinue or adjust your dose without consulting your healthcare provider, who will guide you on how to do so safely.

• Hallucinations and Behavioral Changes: Sinemet can cause hallucinations and behavioral changes, including paranoia, delusions, confusion, and aggressive behavior. These symptoms may occur soon after starting the medication and typically resolve upon discontinuation or dose reduction. Avoid using Sinemet if you have certain mental health conditions, as some mental health medications can exacerbate Parkinson's symptoms or interfere with Sinemet's efficacy.

• Impulsive Behavior: The medication may lead to impulsive behaviors such as strong urges for sex, gambling, spending, or binge eating. These urges can be difficult to control and may negatively impact your life. Discuss any such changes with your healthcare provider, who might inquire about these behaviors during your visits.

• Skin Cancer Risk: Individuals with Parkinson's disease have an increased risk of skin cancer. Regularly monitor for new or unusual skin growths or changes in moles, and report these to your healthcare provider. Periodic skin examinations may be recommended.

• Contraindications: Sinemet should not be used in conjunction with nonselective monoamine oxidase inhibitors (MAOIs) or if you have narrow-angle glaucoma. Consult your healthcare provider if these conditions apply to you before starting Sinemet.

In case of an overdose, seek emergency medical attention immediately. Always adhere to your healthcare provider's instructions for safe use of this medication.

When taking this medication, some common side effects may occur, but they are generally mild and should not cause alarm. These include nausea, dizziness, headache, vomiting, unusual dreams, and lightheadedness. Occasionally, you might experience a loss of appetite or trouble sleeping. Additionally, the medication can cause saliva, sweat, or urine to appear darker, which is harmless but can stain clothing. To minimize dizziness and lightheadedness, rise slowly from sitting or lying positions.

There are also some less common side effects that require attention if they persist or worsen. These include involuntary movements, confusion, hallucinations, depression, and shortness of breath. You might also experience cold-like symptoms, such as a common cold or a urinary tract infection. If any of these effects become bothersome, it's important to consult your healthcare provider.

In rare instances, serious side effects may occur, necessitating immediate medical attention. These include neuroleptic malignant syndrome, characterized by very high fevers, severe confusion, muscle stiffness, changes in blood pressure, and irregular pulse. Other severe symptoms that require urgent care include chest pain, fainting, unusual strong urges, severe stomach pain, and signs of infection like a persistent sore throat. An allergic reaction, though rare, may manifest as a rash, severe dizziness, or trouble breathing, and requires prompt medical intervention.

Lastly, some individuals have reported falling asleep suddenly during daily activities without prior drowsiness, which could pose safety risks. If this occurs, avoid driving or engaging in activities that require alertness until you discuss this with your doctor. Always report any side effects you experience to your healthcare provider for further guidance.

Avoid using this medication with MAO inhibitors, as it can lead to a severe and potentially life-threatening reaction. Do not take MAO inhibitors like isocarboxazid, Linezolid, Metaxalone, methylene blue, moclobemide, phenelzine, procarbazine, or Tranylcypromine while on this medication. Additionally, most MAO inhibitors should be avoided for two weeks before starting this treatment. However, some MAO inhibitors such as Rasagiline, safinamide, and Selegiline might be taken under close supervision by your doctor. Discuss with your doctor the appropriate times to begin or discontinue this medication.

This medication may also affect the results of certain laboratory tests (including urine tests for catecholamines, glucose, or ketones), potentially leading to incorrect results. Inform the laboratory staff and all your healthcare providers that you are using this medication.